References and Notes
1a
Basavaiah D.
Rao AJ.
Satyanarayana T.
Chem. Rev.
2003,
103:
811
1b
Lee KY.
Gowrisankar S.
Kim JN.
Bull. Korean Chem. Soc.
2005,
26:
1481
2a
Hong WP.
Lee K.
Synthesis
2006,
963
2b
Basavaiah D.
Bakthadoss M.
Pandiaraju S.
Chem. Commun.
1998,
1639
2c
Chung YM.
Lee HJ.
Hwang SS.
Kim JN.
Bull. Korean Chem. Soc.
2001,
22:
799
3a
Loh T.-P.
Cao G.-Q.
Pei J.
Tetrahedron Lett.
1998,
39:
1457
3b
Basavaiah D.
Suguna Hyma R.
Tetrahedron
1996,
52:
1253
3c
Sugahara T.
Ogasawara K.
Synlett
1999,
419
3d
Iura Y.
Sugahara T.
Ogasawara K.
Org. Lett.
2001,
3:
291
3e
Vijaya Anand R.
Baktharaman S.
Singh VK.
Tetrahedron Lett.
2002,
43:
5393
4a
Walczak MC.
Coleman RS.
Org. Lett.
2005,
7:
2289
4b
Trauner D.
Miller AK.
Byun DH.
Beaudry CM.
Proc. Natl. Acad. Sci. U.S.A.
2004,
101:
12019
5
Ayerd TB.
Villieras J.
Amri H.
Tetrahedron
2000,
56:
805
6
Taniguchi M.
Hino T.
Kishi Y.
Tetrahedron Lett.
1986,
39:
4767
7
Zhang C.
Lu X.
Synthesis
1996,
586
8
Wei H.-X.
Gao JJ.
Li G.
Paré PW.
Tetrahedron Lett.
2002,
43:
5677
9a
Wei H.-X.
Chen D.
Xu X.
Li G.
Paré PW.
Tetrahedron: Asymmetry
2003,
14:
971
9b
Wei H.-X.
Hu J.
Purkiss DW.
Paré PW.
Tetrahedron Lett.
2003,
44:
949
9c
Deng G.-H.
Hu H.
Wei H.-X.
Paré PW.
Helv. Chim. Acta
2003,
86:
3510
9d
Wei H.-X.
Hu J.
Jasoni RL.
Li G.
Paré PW.
Helv. Chim. Acta
2004,
87:
2359
10 AlI3 appeared superior to other metal iodides, such as MgI2 (79% yield, Z/E = 91:9) or TiI4 (<10% yield) in terms of Z/E selectivity and chemical yield when using benzaldehyde as the electrophilic acceptor.
11a
Chen D.
Timmons C.
Liu J.
Headley A.
Li G.
Eur. J. Org. Chem.
2004,
3330
11b
Chen D.
Guo L.
Saibabu Kotti SRS.
Li G.
Tetrahedron: Asymmetry
2005,
16:
1757
12 The formation of allenoate was expected from the isolation of β-iodo ethyl acrylate after aqueous work-up without adding electrophilic acceptors.
13
Experimental Procedure: CH2Cl2 (2.0 mL) was slowly added to an aluminum iodide (0.22 mmol) at -78 °C under N2. Ethyl propiolate (0.24 mmol) and the ketone (0.20 mmol) were added sequentially. The reaction was monitored by TLC. After the reaction time indicated in Table
[1]
, it was quenched with H2O (2.0 mL) and an aqueous layer was extracted with CH2Cl2. The combined organic phase was dried over Na2SO4 and the solvent was removed under vacuum. The crude product was purified by column chromatography (CH2Cl2-hexane 3:1) to provide a pure product.
(
Z
)-Ethyl 3-[4-(Trifluoromethyl)phenyl]-3-hydroxy-2-(iodomethylene)butanoate (Entry 13).
IR: 3476, 2983, 1718, 1327, 1124, 845 cm-1. 1H NMR (500 MHz, CDCl3): δ = 7.60 (2 H, d, J = 8.0 Hz), 7.54 (2 H, d, J = 8.5 Hz), 7.24 (1 H, s), 4.17 (2 H, m), 4.08 (1 H, br s), 1.70 (3 H, s), 1.16 (3 H, t, J = 7.5 Hz). 13C NMR (125 MHz, CDCl3): δ = 167.74, 149.20, 148.92, 129.95 (q, J = 129.5 Hz), 125.71, 125.53, 124.26 (q, J = 540.8 Hz), 84.81, 77.89, 62.05, 28.94, 13.98. MS: m/e (relative intensity) = 414 (0.2) [M+], 399 (48), 354 (12), 271 (100), 244 (24), 175 (6).
(
Z
)-Ethyl 3-Hydroxy-2-(iodomethylene)-3-(4-methoxy-phenyl)butanoate (Entry 14).
IR: 3464, 2920, 1719, 1509, 1027, 505 cm-1. 1H NMR (300 MHz, CDCl3): δ = 7.22 (2 H, d, J = 8.7 Hz), 7.03 (1 H, s), 6.86 (2 H, d, J = 8.7 Hz), 4.12 (2 H, q, J = 6.9 Hz), 3.66 (1 H, s), 1.70 (3 H, s), 1.53 (3 H, s) 1.19 (3 H, t, J = 7.2 Hz). 13C NMR (125 MHz, CDCl3): δ = 168.04, 159.13, 150.59, 136.97, 130.58, 113.82, 83.26, 77.80, 61.78, 55.47, 28.94, 14.09. MS: m/e (relative intensity) = 377 (0.3) [M+], 361 (15), 232 (30), 203 (100), 152 (43).
(
Z
)-Ethyl 3-Hydroxy-2-(iodomethylene)-3-
p
-tolyl-butanoate (Entry 15).
IR: 3490, 2980, 1722, 1298, 1184, 1028, 820 cm-1. 1H NMR (300 MHz, CDCl3): δ = 7.29 (2 H, d, J = 8.4 Hz), 7.13 (2 H, d, J = 8.4 Hz), 7.04 (1 H, s), 4.16 (2 H, m), 3.74 (1 H, s), 2.33 (3 H, s), 1.69 (3 H, s), 1.18 (3 H, t, J = 7.2 Hz). 13C NMR (125 MHz, CDCl3): δ = 167.95, 150.39, 141.96, 137.38, 129.19, 125.26, 83.48, 77.96, 61.76, 28.91, 21.21, 14.04. MS: m/e (relative intensity) = 360 (0.005) [M+], 344 (10), 216 (100), 188 (36), 120 (10).
(
Z
)-Ethyl 3-Hydroxy-2-(iodomethylene)-3-
o
-tolyl-butanoate (Entry 16).
IR: 3498, 2980, 1722, 1295, 1182, 1027, 483 cm-1. 1H NMR (300 MHz, CDCl3): δ = 7.52 (1 H, m), 7.17 (3 H, m), 6.82 (1 H, s), 4.15 (2 H, m), 3.39 (1 H, br s), 2.39 (3 H, s), 1.82 (3 H, s), 1.14 (3 H, t, J = 7.2 Hz). 13C NMR (125 MHz, CDCl3): δ = 167.78, 150.96, 141.63, 136.15, 132.49, 128.82, 126.05, 125.96, 81.78, 78.22, 61.52, 28.69, 21.95, 14.12. MS: m/e (relative intensity) = 359 (0.0015) [M+], 216 (100), 144 (33), 120 (13).
(
Z
)-Ethyl 3-Hydroxy-2-(iodomethylene)-3,4,4-trimethylpentanoate (Entry 18).
IR: 3520, 2958, 1723, 1289, 1180, 503 cm-1. 1H NMR (500 MHz, CDCl3): δ = 6.79 (1 H, s) 4.30 (2 H, m), 2.44 (1 H, br s) 1.45 (1 H, s), 1.37 (3 H, t, J = 7.0 Hz), 0.98 (9 H, s). 13C NMR (125 MHz, CDCl3): δ = 169.14, 152.41, 81.92, 81.08, 61.68, 38.98, 25.81, 24.71, 14.10. MS: m/e (relative intensity) = 326 (0.15) [M+], 309 (100), 272 (30), 226 (13), 146 (10).
(
Z
)-Ethyl 3-Hydroxy-2-(iodomethylene)-3-phenyl-pentanoate (Entry 19).
IR: 3489, 2978, 1721, 1299, 1185, 701 cm-1. 1H NMR (300 MHz, CDCl3): δ = 7.33 (5 H, m) 7.00 (1 H, s), 4.14 (2 H, q, J = 7.2 Hz), 3.58 (1 H, s), 2.06 (2 H, m), 1.14 (3 H, t, J = 5.8 Hz), 0.82 (3 H, t, J = 7.2 Hz). 13C NMR (75 MHz, CDCl3): δ = 168.20, 150.37, 142.72, 128.89, 127.62, 126.14, 83.15, 80.31, 61.77, 32.70, 14.04, 7.95. MS: m/e (relative intensity) = 360 (0.01) [M+], 331 (30), 216 (100), 108 (8).